Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3804)
All Articles published online
|
Feb 27, 2012 (publication date) through Jan 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Giang L, Selinger CP, Lee AU. Evaluation of adherence to oral antiviral hepatitis B treatment using structured questionnaires. World J Hepatol 2012; 4(2): 43-49 [PMID: 22400085 DOI: 10.4254/wjh.v4.i2.43] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v4/i2/43.htm |
| Number | Citing Articles |
| 1 |
Dilip Ratnam, Peter Angus. Global Perspectives: Australia – Real World Experience with HBV Antiviral Therapy. Current Hepatitis Reports 2012; 11(4): 213 doi: 10.1007/s11901-012-0152-4
|
| 2 |
Mayank Jain, Sagar Adkar, Chandrashekhar Waghmare. Adherence to oral antivirals in patients with chronic hepatitis B infection. Indian Journal of Gastroenterology 2014; 33(4): 390 doi: 10.1007/s12664-013-0433-z
|
| 3 |
Spilios Manolakopoulos, Athanasia Striki, Vasilios Papastergiou, Nikoleta Perlepe, Konstantinos Zisimopoulos, Afroditi Papazoglou, Melanie Deutsch, Nikolaos Papadopoulos, Christos Triantos, John Goulis, George Papatheodoridis. Persistence and adherence to nucleos(t)ide analogues in chronic hepatitis B: a multicenter cohort study. European Journal of Gastroenterology & Hepatology 2020; 32(5): 635 doi: 10.1097/MEG.0000000000001558
|
| 4 |
Suzanne Polis, Iryna Zablotska-Manos, Amany Zekry, Lisa Maher. Adherence to Hepatitis B Antiviral Therapy. Gastroenterology Nursing 2017; 40(3): 239 doi: 10.1097/SGA.0000000000000161
|
| 5 |
Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen, James Fung. Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy. Expert Review of Gastroenterology & Hepatology 2023; 17(5): 443 doi: 10.1080/17474124.2023.2196405
|
| 6 |
Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han. Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea. Infectious Diseases and Therapy 2023; 12(10): 2387 doi: 10.1007/s40121-023-00860-8
|
| 7 |
Nathan Ford, Roz Scourse, Maud Lemoine, Yvan Hutin, Marc Bulterys, Zara Shubber, Dmytro Donchuk, Gilles Wandeler. Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta‐Analysis. Hepatology Communications 2018; 2(10): 1160 doi: 10.1002/hep4.1247
|
| 8 |
Jolynne Mokaya, Anna L. McNaughton, Phillip A Bester, Dominique Goedhals, Eleanor Barnes, Brian D Marsden, Philippa C. Matthews. Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms. Wellcome Open Research 2020; 5: 151 doi: 10.12688/wellcomeopenres.15992.1
|
| 9 |
Hirofumi Go, Makoto Tanaka, Noriko Yamamoto-Mitani, Miho Suzuki, Aki Kawakami, Naohiko Masaki, Megumi Shimada. Medication Adherence Among Patients With Chronic Hepatitis Receiving Antiviral Treatment. Gastroenterology Nursing 2019; 42(2): 140 doi: 10.1097/SGA.0000000000000363
|
| 10 |
Christian P. Selinger, Andrew Robinson. The Handbook of Behavioral Medicine. 2014; : 23 doi: 10.1002/9781118453940.ch2
|
| 11 |
Suzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Jacob George, Amany Zekry, Lisa Maher. Factors Associated with Non-Adherence to HBV Antiviral Therapy. Antiviral Therapy 2018; 23(5): 425 doi: 10.3851/IMP3219
|
| 12 |
Benedetto Caroleo, Orietta Staltari, Luca Gallelli, Francesco Perticone. Reactivation of chronic hepatitis B during treatment with tenofovir disoproxil fumarate: drug interactions or low adherence?. BMJ Case Reports 2015; : bcr2015209586 doi: 10.1136/bcr-2015-209586
|
| 13 |
Suzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Amany Zekry, Gregory J Dore, Jacob George, Lisa Maher. Factors associated with HBV Virological Breakthrough. Antiviral Therapy 2017; 22(1): 53 doi: 10.3851/IMP3087
|
| 14 |
H. Chi, A. Japhary, R. A. de Man, R. J. de Knegt, H. L. A. Janssen, B. E. Hansen. Younger age and language barriers are associated with nonadherence to clinical follow‐up in hepatitis B treatment. Journal of Viral Hepatitis 2018; 25(10): 1216 doi: 10.1111/jvh.12920
|
| 15 |
Yueyue Li, Anni Chen, Hui Wang, Lu Han, Rong Wang, Guoqing Zhang, Yongfang Yuan. Treatment Adherence to Nucleos(t)ide Analogs in Chinese Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Single-Center Cross-Sectional Study. Patient Preference and Adherence 2021; : 1729 doi: 10.2147/PPA.S317250
|
| 16 |
Ling-Na Kong, Ying Guo, Bo Qin, Xin Peng, Wen-Fen Zhu, Mario U. Mondelli. Development of Self-Management Indicators for Chronic Hepatitis B Patients on Antiviral Therapy: Results of a Chinese Delphi Panel Survey. PLOS ONE 2015; 10(9): e0134125 doi: 10.1371/journal.pone.0134125
|
| 17 |
Rodrigo M Abreu, Leda C Bassit, Sijia Tao, Yong Jiang, Aline S Ferreira, Patrícia CA Hori, Lilia M Ganova-Raeva, Yury Khudyakov, Raymond F Schinazi, Flair J Carrilho, Suzane K Ono. Long-term Virological and Adherence Outcomes to Antiviral Treatment in a 4-year Cohort Chronic HBV Study. Antiviral Therapy 2019; 24(8): 567 doi: 10.3851/IMP3338
|
| 18 |
N. Allard, A. Dev, J. Dwyer, G. Srivatsa, A. Thompson, B. Cowie. Factors associated with poor adherence to antiviral treatment for hepatitis B. Journal of Viral Hepatitis 2017; 24(1): 53 doi: 10.1111/jvh.12582
|
| 19 |
Faydra I. Lieveld, Lotte G. van Vlerken, Peter D. Siersema, Karel J van Erpecum. Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review. Annals of Hepatology 2013; 12(3): 380 doi: 10.1016/S1665-2681(19)31000-2
|
| 20 |
玉娇 常. Progress of Research on the Current Status and Influencing Factors of Medication Adherence in Chronic Hepatitis B Patients. Advances in Clinical Medicine 2024; 14(05): 787 doi: 10.12677/acm.2024.1451492
|
| 21 |
Kerui Xu, Li-Ming Liu, Paraskevi A. Farazi, Hongmei Wang, Fedja A Rochling, Shinobu Watanabe-Galloway, Jian-Jun Zhang. Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B. Global Health Action 2018; 11(1): 1433987 doi: 10.1080/16549716.2018.1433987
|
| 22 |
Zahra Taheri Ezbarami, Parkhideh Hassani, Mansoureh Zagheri Tafreshi, Hamid Alavi Majd. A qualitative study on individual experiences of chronic hepatitis B patients. Nursing Open 2017; 4(4): 310 doi: 10.1002/nop2.100
|
| 23 |
Marco Vincenzo Lenti, Christian P. Selinger. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions. Expert Review of Gastroenterology & Hepatology 2017; : 1 doi: 10.1080/17474124.2017.1284587
|
| 24 |
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements. Journal of Clinical and Experimental Hepatology 2018; 8(1): 58 doi: 10.1016/j.jceh.2017.12.001
|